← Back to headlines
AbbVie's Allergan Aesthetics Receives FDA Approval for Skinvive by Juvederm
AbbVie's Allergan Aesthetics division has secured FDA approval for its new product, Skinvive by Juvederm, expanding its portfolio of aesthetic treatments.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Asian Markets Fall and Oil Prices Rise Amid Escalating US-Iran Tensions
1h ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
1h ago
Apple Sets Executive Pay for New CEO John Ternus and Chair Tim Cook
1h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
2h ago